{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T01:36:41Z","timestamp":1792287401797,"version":"4.4.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.ygyno.2018.11.034","type":"journal-article","created":{"date-parts":[[2018,12,14]],"date-time":"2018-12-14T13:04:57Z","timestamp":1544792697000},"page":"259-264","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":89,"title":["Systemic immune-inflammation index predicts prognosis in patients with epithelial ovarian cancer: A retrospective study"],"prefix":"10.1016","volume":"152","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0750-6445","authenticated-orcid":false,"given":"Dan","family":"Nie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiguang","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1995-9812","authenticated-orcid":false,"given":"Zhengyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2018.11.034_bb0005","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3322\/caac.20113","article-title":"Recent progress in the diagnosis and treatment of ovarian cancer","volume":"61","author":"Jelovac","year":"2011","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ygyno.2018.11.034_bb0010","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/S0140-6736(13)62146-7","article-title":"Ovarian cancer","volume":"384","author":"Jayson","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.ygyno.2018.11.034_bb0015","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2016.61","article-title":"Ovarian cancer","volume":"2","author":"Matulonis","year":"2016","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.ygyno.2018.11.034_bb0020","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","article-title":"Immunity, inflammation, and cancer","volume":"140","author":"Grivennikov","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.ygyno.2018.11.034_bb0025","doi-asserted-by":"crossref","first-page":"e493","DOI":"10.1016\/S1470-2045(14)70263-3","article-title":"Cancer-related inflammation and treatment effectiveness","volume":"15","author":"Diakos","year":"2014","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ygyno.2018.11.034_bb0030","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.ygyno.2018.11.034_bb0035","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1038\/bjc.2013.522","article-title":"Pre-treatment neutrophil-to-lymphocyte ratio may be associated with the outcome in patients treated with everolimus for metastatic renal cell carcinoma","volume":"109","author":"Santoni","year":"2013","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ygyno.2018.11.034_bb0040","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1097\/SLA.0000000000001743","article-title":"The lymphocyte-to-monocyte ratio is a superior predictor of overall survival in comparison to established biomarkers of resectable colorectal cancer","volume":"265","author":"Chan","year":"2017","journal-title":"Ann. Surg."},{"key":"10.1016\/j.ygyno.2018.11.034_bb0045","article-title":"Peripheral platelet\/lymphocyte ratio predicts lymph node metastasis and acts as a superior prognostic factor for cervical cancer when combined with neutrophil: lymphocyte","volume":"95","author":"Chen","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ygyno.2018.11.034_bb0050","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ejogrb.2018.05.028","article-title":"Prognostic value of pre-operative neutrophil\/lymphocyte ratio, monocyte count, mean platelet volume, and platelet\/lymphocyte ratio in endometrial cancer","volume":"226","author":"Temur","year":"2018","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/j.ygyno.2018.11.034_bb0055","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3233\/CBM-160614","article-title":"Neutrophil to lymphocyte ratio and platelet to lymphocyte ratio are predictive of chemotherapeutic response and prognosis in epithelial ovarian cancer patients treated with platinum-based chemotherapy","volume":"17","author":"Miao","year":"2016","journal-title":"Cancer Biomark."},{"key":"10.1016\/j.ygyno.2018.11.034_bb0060","doi-asserted-by":"crossref","first-page":"265","DOI":"10.3802\/jgo.2012.23.4.265","article-title":"Platelet to lymphocyte ratio as a prognostic factor for epithelial ovarian cancer","volume":"23","author":"Raungkaewmanee","year":"2012","journal-title":"J. Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2018.11.034_bb0065","doi-asserted-by":"crossref","first-page":"6212","DOI":"10.1158\/1078-0432.CCR-14-0442","article-title":"Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma","volume":"20","author":"Hu","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ygyno.2018.11.034_bb0070","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1515\/cclm-2015-1191","article-title":"Dynamic change of the systemic immune inflammation index predicts the prognosis of patients with hepatocellular carcinoma after curative resection","volume":"54","author":"Wang","year":"2016","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.ygyno.2018.11.034_bb0075","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1620\/tjem.236.297","article-title":"Systemic immune-inflammation index, based on platelet counts and neutrophil-lymphocyte ratio, is useful for predicting prognosis in small cell lung cancer","volume":"236","author":"Hong","year":"2015","journal-title":"Tohoku J. Exp. Med."},{"key":"10.1016\/j.ygyno.2018.11.034_bb0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijgo.2013.10.001","article-title":"Staging classification for cancer of the ovary, fallopian tube, and peritoneum","volume":"124","author":"Prat","year":"2014","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"10.1016\/j.ygyno.2018.11.034_bb0085","doi-asserted-by":"crossref","first-page":"33210","DOI":"10.18632\/oncotarget.8901","article-title":"Inflammatory indexes as predictors of prognosis and bevacizumab efficacy in patients with metastatic colorectal cancer","volume":"7","author":"Passardi","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.ygyno.2018.11.034_bb0090","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s11523-018-0574-1","article-title":"Inflammatory indexes as prognostic and predictive factors in ovarian cancer treated with chemotherapy alone or together with bevacizumab. A multicenter, retrospective analysis by the MITO Group (MITO 24)","volume":"13","author":"Farolfi","year":"2018","journal-title":"Target. Oncol."},{"key":"10.1016\/j.ygyno.2018.11.034_bb0095","doi-asserted-by":"crossref","first-page":"8831","DOI":"10.1007\/s13277-015-3533-9","article-title":"Preoperative platelet\/lymphocyte ratio is a superior prognostic factor compared to other systemic inflammatory response markers in ovarian cancer patients","volume":"36","author":"Zhang","year":"2015","journal-title":"Tumour Biol."},{"key":"10.1016\/j.ygyno.2018.11.034_bb0100","doi-asserted-by":"crossref","first-page":"7252","DOI":"10.1158\/1078-0432.CCR-04-0713","article-title":"X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization","volume":"10","author":"Camp","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ygyno.2018.11.034_bb0105","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1158\/0008-5472.CAN-10-2583","article-title":"Tumor-associated neutrophils: new targets for cancer therapy","volume":"71","author":"Gregory","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.ygyno.2018.11.034_bb0110","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.ccr.2011.09.009","article-title":"Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis","volume":"20","author":"Labelle","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ygyno.2018.11.034_bb0115","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1053\/j.seminoncol.2014.04.004","article-title":"Platelet effects on ovarian cancer","volume":"41","author":"Davis","year":"2014","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.ygyno.2018.11.034_bb0120","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/s41467-017-00411-z","article-title":"Platelets reduce anoikis and promote metastasis by activating YAP1 signaling","volume":"8","author":"Haemmerle","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ygyno.2018.11.034_bb0125","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s00262-008-0583-5","article-title":"Prognostic significance of tumor-infiltrating T-lymphocytes in primary and metastatic lesions of advanced stage ovarian cancer","volume":"58","author":"Leffers","year":"2009","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.ygyno.2018.11.034_bb0130","doi-asserted-by":"crossref","DOI":"10.1136\/esmoopen-2016-000039","article-title":"Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio before chemotherapy as potential prognostic factors in patients with newly diagnosed epithelial ovarian cancer","volume":"1","author":"Badora-Rybicka","year":"2016","journal-title":"ESMO Open"},{"key":"10.1016\/j.ygyno.2018.11.034_bb0135","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1038\/bjc.2017.460","article-title":"Systemic immune-inflammation index in germ-cell tumours","volume":"118","author":"Chovanec","year":"2018","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ygyno.2018.11.034_bb0140","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.ygyno.2016.01.016","article-title":"HE4, CA125 and risk of ovarian malignancy algorithm (ROMA) as diagnostic tools for ovarian cancer in patients with a pelvic mass: an Italian multicenter study","volume":"141","author":"Romagnolo","year":"2016","journal-title":"Gynecol. Oncol."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825818314549?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825818314549?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,16]],"date-time":"2019-10-16T10:42:43Z","timestamp":1571222563000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825818314549"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["S0090825818314549"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2018.11.034","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systemic immune-inflammation index predicts prognosis in patients with epithelial ovarian cancer: A retrospective study","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2018.11.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}